Imprint Medicine is an epigenetic editing company developing one-time gene therapies for diseases with high unmet medical needs. Powered by state-of-the-art protein engineering, we are creating novel epigenetic editors, designed for efficiency, precision and safety. Our technology enables targeted control of gene regulation in disease-relevant tissues without causing DNA breaks or making changes to the genome.